StockWatch
·
Pharmaceuticals
Quarterly Result26 May 2026, 05:11 pm

P&G Health FY26: Revenue from Operations ₹1407.97 Cr

AI Summary

Procter & Gamble Health Ltd's audited financial results for the year ended March 31, 2026, were approved in a board meeting held on May 26, 2026. The company reported revenue from operations of ₹1407.97 Cr and a net profit of ₹326.91 Cr for the financial year ended March 31, 2026. The Board recommended a dividend of ₹45 per equity share (Nominal Value of ₹10 each), to be paid on or before September 25, 2026, subject to member approval.

Key Highlights

  • Audited financial results for FY26 approved by the Board on May 26, 2026.
  • Recommended dividend of ₹45 per equity share for FY26.
  • Revenue from Operations for FY26 stood at ₹1407.97 Cr.
  • Net Profit for FY26 was reported as ₹326.91 Cr.